MJH Life Sciences Acquires Revolutionizing Atopic Dermatitis (RAD) Annual Meeting

November 18, 2024

MJH Life Sciences has acquired the Revolutionizing Atopic Dermatitis (RAD) Annual Meeting, a CME-certified conference focused on advances in dermatology. The meeting will be integrated into MJH's multichannel education model and the legacy meetings portfolio of Physicians' Education Resource (PER), expanding MJH's dermatology education offerings with support from its established brands and PE backers.

Buyers
MJH Life Sciences
Targets
Revolutionizing Atopic Dermatitis (RAD) Annual Meeting
Location
New Jersey, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.